Cargando…
Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease
In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) commenced in Wuhan, China and affected around 210 countries and territories in a matter of weeks. It has a phylogenetic similarity to SARS-CoV and it was named coronavirus 2 (SARS-CoV-2) and caused severe acute respiratory syndrome...
Autores principales: | Owis, Asmaa I., El-Hawary, Marwa S., El Amir, Dalia, Aly, Omar M., Abdelmohsen, Usama Ramadan, Kamel, Mohamed S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054211/ https://www.ncbi.nlm.nih.gov/pubmed/35515460 http://dx.doi.org/10.1039/d0ra03582c |
Ejemplares similares
-
Flavonoids of Salvadora persica L. (meswak) and its liposomal formulation as a potential inhibitor of SARS-CoV-2
por: Owis, Asmaa I., et al.
Publicado: (2021) -
Salvadora persica
por: Khatak, M., et al.
Publicado: (2010) -
Purification and characterization of cysteine protease from miswak Salvadora persica
por: Abdulaal, Wesam H.
Publicado: (2018) -
Metabolic profiling and biological activity of two Livistona species: L. chinensis and L. australis
por: El-hawary, Seham S., et al.
Publicado: (2023) -
Tamarix arabica and Salvadora persica as antibacterial agents
por: Al-Judaibi, Awatif A.
Publicado: (2020)